<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01292538</url>
  </required_header>
  <id_info>
    <org_study_id>EC-GREEN001</org_study_id>
    <nct_id>NCT01292538</nct_id>
  </id_info>
  <brief_title>Study of the Effectiveness of Green Diode Laser Light on Body Shaping</brief_title>
  <official_title>A Double-blind, Placebo-controlled Randomized Evaluation of the Effect of the Erchonia Scanner Device (GLS) Green Diode on Body Contouring of the Waist, Hips and Thighs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erchonia Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erchonia Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if 532nm green diode laser light is effective in
      body contouring of the waist, hips and thighs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Weight loss and body contouring are large, constantly-growing fields of cosmetic surgery.
      However, while the demand for body shaping procedures is constantly on the rise, so is the
      demand for such procedures to be performed more quickly, simply and most importantly, less
      invasively; hence the growing popularity of non- to minimally-invasive cosmetic surgery
      procedures. In 2005, more than 7.5 million minimally-invasive cosmetic procedures were
      performed, a 35% increase from 2000.

      In recent years, Erchonia Corporation, a manufacturer of low level lasers, has developed a
      dual-diode laser that emits 532 nm and 635nm collimated line-generated beams to emulsify fat.
      In August, 2010, the Erchonia® ML Scanner (MLS) 635nm was cleared by FDA for use as a
      non-invasive dermatological aesthetic treatment for the reduction of circumference of hips,
      waist, and thighs. It was determined that the biochemical effect of the Erchonia® MLS
      stimulates the mitochondria of the adipocyte cells which in turn increases the production of
      ATP. The newly synthesized ATP triggers the up-regulation of cyclic adenosine monophosphate
      (cAMP). cAMP has been shown to stimulate cytoplasmic lipase, triggering the conversion of
      triglycerides into fatty acids and glycerol that can easily pass through the cell membrane.
      The transitory pore is evidence that the laser is allowing for the movement of fatty acids,
      glycerol, and triglycerides to pass across the membrane and into extra-cellular space.
      Through vasodilation of nearby blood vessels and arteries, oxidization of the triglycerides
      and fatty acids occurs within the extra-cellular space.

      This pilot study will apply the Erchonia® MLS employing 532 nm green diodes in lieu of 635 nm
      red diodes to compare the results to those attained using the 635 nm diodes. The Sponsor
      believes the use of 532 nm diodes may prove as effective as 635 nm diodes combined with a
      reduction in total procedure administration time from 40 to 30 minutes. It is the goal of
      this study to evaluate this hypothesis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs</measure>
    <time_frame>2 weeks</time_frame>
    <description>Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Self-reported Satisfaction With Study Outcome</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight (Pounds)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Body Contouring</condition>
  <arm_group>
    <arm_group_label>Erchonia GLS 532nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>532nm green laser light therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo laser</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham light output with no therapeutic benefit</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Erchonia GLS</intervention_name>
    <description>532 nm green diode low level laser light device</description>
    <arm_group_label>Erchonia GLS 532nm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo laser</intervention_name>
    <description>Sham light output with no therapeutic benefit</description>
    <arm_group_label>Placebo laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index (BMI) less than 30 kg/m²

          -  Subject indicated for liposuction or use of liposuction techniques for the removal of
             localized deposits of adipose tissues that do not respond to diet and exercise;
             specifically for the indication of body contouring in the areas of the waist, hips and
             bilateral thighs. (As per the American Academy of Cosmetic Surgery's 2006 Guidelines
             for Liposuction Surgery).

          -  Subject is willing and able to abstain from partaking in any treatment other than the
             study procedure to promote body contouring and/or weight loss during study
             participation.

          -  Subject is willing and able to maintain his or her regular diet and exercise regimen
             without effecting significant change in either direction during study participation.

        Exclusion Criteria:

          -  Body Mass Index (BMI) of 30 kg/m² or greater.

          -  Diabetic dependent on insulin or oral hypoglycemic medications.

          -  Known cardiovascular disease.

          -  Prior cardiac surgery.

          -  Prior surgical intervention for body sculpting/weight loss, such as liposuction,
             abdominoplasty, stomach stapling, lap band surgery.

          -  Medical, physical, or other contraindications for body sculpting/weight loss.

          -  Use of medication(s) known to affect weight levels and/or to cause bloating or
             swelling and for which abstinence during study participation is not safe or medically
             prudent.

          -  Any medical condition known to affect weight levels and/or cause bloating or swelling.

          -  Diagnosis of, and/or taking medication for, irritable bowel syndrome.

          -  Active infection, wound or other external trauma to the areas to be treated with the
             laser.

          -  Photosensitivity disorder.

          -  Current cancer or receiving treatment for cancer.

          -  Pregnant, breast feeding, or planning pregnancy prior to study end.

          -  Serious mental health illness such as dementia or schizophrenia; psychiatric
             hospitalization in past two years.

          -  Developmental disability or cognitive impairment that would preclude adequate
             comprehension of the informed consent form and/or ability to record study
             measurements.

          -  Involvement in litigation and/or a worker's compensation claim and/or receiving
             disability benefits related to weight-related/body shape issues.

          -  Participation in research in the past 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory C Roche, MD, FACS</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Robert F Jackson, MD, FACS</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Surgeon's Inc.</name>
      <address>
        <city>Marion</city>
        <state>Indiana</state>
        <zip>46952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bloomfield Laser and Cosmetic Surgery Center</name>
      <address>
        <city>Bloomfield Hills</city>
        <state>Michigan</state>
        <zip>48302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2011</study_first_submitted>
  <study_first_submitted_qc>February 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2011</study_first_posted>
  <results_first_submitted>April 1, 2014</results_first_submitted>
  <results_first_submitted_qc>May 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 3, 2014</results_first_posted>
  <last_update_submitted>May 7, 2014</last_update_submitted>
  <last_update_submitted_qc>May 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Erchonia GLS 532nm</title>
          <description>532nm green laser light therapy.
Erchonia GLS: 532 nm green diode low level laser light device</description>
        </group>
        <group group_id="P2">
          <title>Placebo Laser</title>
          <description>Sham light output with no therapeutic benefit
Placebo laser: Sham light output with no therapeutic benefit</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Erchonia GLS 532nm</title>
          <description>532nm green laser light therapy.
Erchonia GLS: 532 nm green diode low level laser light device</description>
        </group>
        <group group_id="B2">
          <title>Placebo Laser</title>
          <description>Sham light output with no therapeutic benefit
Placebo laser: Sham light output with no therapeutic benefit</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="67"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.60" spread="10.05"/>
                    <measurement group_id="B2" value="39.03" spread="10.16"/>
                    <measurement group_id="B3" value="38.04" spread="10.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs</title>
        <description>Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Erchonia GLS 532nm</title>
            <description>532nm green laser light therapy.
Erchonia GLS: 532 nm green diode low level laser light device</description>
          </group>
          <group group_id="O2">
            <title>Placebo Laser</title>
            <description>Sham light output with no therapeutic benefit
Placebo laser: Sham light output with no therapeutic benefit</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs</title>
          <description>Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.</description>
          <units>inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.895" spread="3.03"/>
                    <measurement group_id="O2" value="-1.136" spread="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (BMI)</title>
        <time_frame>2 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Self-reported Satisfaction With Study Outcome</title>
        <time_frame>2 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight (Pounds)</title>
        <time_frame>2 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Erchonia GLS 532nm</title>
          <description>532nm green laser light therapy.
Erchonia GLS: 532 nm green diode low level laser light device</description>
        </group>
        <group group_id="E2">
          <title>Placebo Laser</title>
          <description>Sham light output with no therapeutic benefit
Placebo laser: Sham light output with no therapeutic benefit</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elvira Walls</name_or_title>
      <organization>Regulatory Insight, Inc.</organization>
      <phone>615-712-9743</phone>
      <email>elvira@reginsight.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

